Asif Raza

Asif Raza's work focuses on designing and synthesizing new chemical compounds—such as triazole, isatin, selenium-containing, and coumarin-based molecules—and testing their ability to kill or slow the growth of cancer cells, particularly breast, prostate, and pancreatic cancers. The research combines organic chemistry synthesis with biological testing (cytotoxicity assays) and computational modeling (molecular docking) to identify promising drug candidates. Some publications also touch on antimicrobial applications and unrelated topics like engineering materials and AI strategy, suggesting involvement in diverse collaborative projects.

Publication output increased notably starting in 2022 (jumping from single digits to 10-16 papers per year) and has remained high through 2025, indicating a growing and currently active publication record over the last decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026